NCT01858896View on ClinicalTrials.gov

GLP-1 and Hypoglycemia

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Glucagon-Like Peptide- 1 (GLP-1) infusion

GLP-1 infusion during experimental period

OTHER

Placebo Comparator: Saline Infusion

Saline infusion (placebo) during experimental period

Trial Locations (1)

21201

University of Maryland, Baltimore, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER